I agree with this comment. It’s worth nothing that the methodology used in this analysis isn’t the same as the methodology used in the CURVE sequence. In the “How Can Risk Aversion Affect Your Cause Prioritization” report, @Laura Duffy weighted 1 year of disabling pain at 2 to 10 DALYs and 1 year of excruciating pain at 60 to 150 DALYs. I expect that dying is at least disablingly painful and potentially excruciatingly painful, so these weights would imply a >5x improvement in cost-effectiveness (but even at the upper end, this probably wouldn’t be cost-competitive with top EA interventions).
In general, I think it’s a good step to try and actually put interventions from different cause areas on the same scale, but I continue to think that because DALYs are a unit of health status and not a unit of utility, trying to use them as a unit of comparison is unlikely to be optimal (see here and here for more)
I would agree on that this intervention would look better (in $/DALY space) if I were to have adopted the same assumptions as @Laura Duffy and come up with some plausible assumptions how much time in various pain intensities that would be averted through the intervention. I also think its very unlikely the intervention would look competitive the top AW and GHD interventions. Under the assumptions where this intervention were to look very competitive, I’d suspect shrimp stunning interventions would look even better.
Thanks also for your very valid comments on using DALYs as a unit to compare interventions (and your general engagement on the research that @Rethink Priorities does!).
I agree with this comment. It’s worth nothing that the methodology used in this analysis isn’t the same as the methodology used in the CURVE sequence. In the “How Can Risk Aversion Affect Your Cause Prioritization” report, @Laura Duffy weighted 1 year of disabling pain at 2 to 10 DALYs and 1 year of excruciating pain at 60 to 150 DALYs. I expect that dying is at least disablingly painful and potentially excruciatingly painful, so these weights would imply a >5x improvement in cost-effectiveness (but even at the upper end, this probably wouldn’t be cost-competitive with top EA interventions).
In general, I think it’s a good step to try and actually put interventions from different cause areas on the same scale, but I continue to think that because DALYs are a unit of health status and not a unit of utility, trying to use them as a unit of comparison is unlikely to be optimal (see here and here for more)
Thank you for your comments, Matt!
I would agree on that this intervention would look better (in $/DALY space) if I were to have adopted the same assumptions as @Laura Duffy and come up with some plausible assumptions how much time in various pain intensities that would be averted through the intervention. I also think its very unlikely the intervention would look competitive the top AW and GHD interventions. Under the assumptions where this intervention were to look very competitive, I’d suspect shrimp stunning interventions would look even better.
Thanks also for your very valid comments on using DALYs as a unit to compare interventions (and your general engagement on the research that @Rethink Priorities does!).